Kedaara gets over 5X returns from Vijaya Diagnostic

By Ankit Agarwal

  • 26 Aug 2021
Premium
Credit: 123RF.com

Homegrown private equity firm Kedaara is sitting on attractive annualized returns of 44% from its investment in IPO-bound Vijaya Diagnostics, according to VCCircle estimates. IPO-bound Vijaya Diagnostic Centre’s issue, which is purely an offer-for-sale of up to 35.69 million shares, will get the promoters and Kedaara up to Rs.1,895 crore. Kedaara, ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.